TrustCore Financial Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-634
Closed -$16K 1144
2022
Q3
$16K Hold
634
﹤0.01% 661
2022
Q2
$21K Hold
634
﹤0.01% 634
2022
Q1
$46K Hold
634
﹤0.01% 494
2021
Q4
$58K Sell
634
-800
-56% -$95.6K 0.01% 414
2021
Q3
$182K Sell
1,434
-275
-16% -$40K 0.02% 277
2021
Q2
$284K Hold
1,709
0.03% 231
2021
Q1
$311K Sell
1,709
-300
-15% -$69.6K 0.04% 206
2020
Q4
$402K Sell
2,009
-700
-26% -$142K 0.05% 177
2020
Q3
$594K Buy
2,709
+175
+7% +$37.1K 0.09% 124
2020
Q2
$484K Buy
2,534
+1,434
+130% +$251K 0.08% 144
2020
Q1
$171K Buy
1,100
+700
+175% +$81.4K 0.04% 209
2019
Q4
$33K Hold
400
0.01% 441
2019
Q3
$27K Hold
400
0.01% 460
2019
Q2
$27K Sell
400
-400
-50% -$23.3K 0.01% 457
2019
Q1
$44K Buy
800
+400
+100% +$24.4K 0.01% 325
2018
Q4
$20K Sell
400
-500
-56% -$30.6K 0.01% 220
2018
Q3
$78K Buy
+900
New +$64.1K 0.02% 257

Other funds holding TDOC

TrustCore Financial Services's TDOC Position: Q4 2022 in Review

TrustCore Financial Services sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 634 shares — an estimated $16K sold.

TrustCore Financial Services first reported a position in TDOC in Q3 2018 and held it in 17 quarters. The position peaked at $594K in Q3 2020. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • TrustCore Financial Services reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 634 Teladoc Health shares in Q4 2022, an estimated $16K.
  • TrustCore Financial Services first reported a position in Teladoc Health in Q3 2018 and held it in 17 quarters.
  • TrustCore Financial Services's Teladoc Health position peaked at $594K in Q3 2020.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.